The Lancet Oncology Commission projects a near-100-million shortfall in cancer care personnel by 2050, driven by rising incidence and persistent training bottlenecks, with nursing and diagnostic imaging roles facing the steepest deficits. This expert-synthesis report, not an RCT or large-scale observational cohort, aggregates global health-system data but lacks primary empirical validation of its workforce modeling assumptions. It correctly identifies survival disparities—projected 34% in Africa versus over 60% in North America—but underplays how international migration of radiologists and oncologists from low-income settings will accelerate the crisis beyond its linear forecasts. Cross-referencing with WHO Global Strategy on Human Resources for Health (2016, updated 2022 observational modeling, n=192 countries) and GLOBOCAN incidence projections reveals compounding effects from post-COVID burnout attrition, unaccounted for in the Commission’s estimates. Scaling diagnostics and training could avert 170 million deaths per the report, yet without addressing regulatory barriers to task-shifting and AI-augmented imaging, economic gains will concentrate in high-income regions. Australia’s regional imaging shortages, highlighted by sole Australian commissioner Professor Andrew Scott, exemplify the same maldistribution pattern seen in sub-Saharan observational workforce audits.